Aim & Scope
Frontiers in Pharmacology publishes tier 1 and tier 2 article types on the most outstanding discoveries across the entire research spectrum of pharmacology including basic pharmacology, clinical pharmacology, medicinal chemistry, pharmacy and toxicology. Pharmacology is a medical science, as was recalled in the anniversary address for the 50th Spring Meeting in Mainz of the German Pharmacological Society in March 2009. This science of the effect of medicinal bodies gives us the handle to clarify the fundamental processes of life. It is also the science studying the interactions between chemicals and living beings directed to prevent, ameliorate or cure the deleterious consequences of their diseases, thereby it provides medicine with weapons against diseases. Those major targets offer the opportunity to segment the field not only in a way considering pure basic topics but also by combining and integrating basic and clinical science. The editorial policy aims at identifying the most productive research projects through an evaluation by the scientific community. Thereby Frontiers editors hope to further pharmacological research. They intend to emphasize a proper use of translational science at both preclinical and clinical levels in order to encourage collaboration between clinicians and basic scientists. Editors welcome papers issued from a collaborative strategy between the academic and the private industrial sectors that could benefit to the reversal of the current decline in the production of original medicines. The mission of Frontiers in Pharmacology is to bring all relevant specialties in pharmacology together on a single platform. Frontiers in Pharmacology publishes articles on the most outstanding discoveries across the entire research spectrum of Pharmacology. The mission of Frontiers in Pharmacology is to bring all relevant Specialties in Pharmacology together on a single platform. [1]
2024 - VOLUME 15
H Wang , P Xia , M Kurboniyon , ... , C Wang
Frontiers in Pharmacology , 2024 - VOLUME 15
Recent advances and applications of nitroreductase activable agents for tumor theranostic
Frontiers in Pharmacology , 2024 - VOLUME 15
Leonurine: a comprehensive review of pharmacokinetics, pharmacodynamics, and toxicology
S Liu , C Sun , H Tang , ... , F Peng
Frontiers in Pharmacology , 2024 - VOLUME 15
RAB42 overexpression correlates with poor prognosis, immune cell infiltration and chemoresistance
Y Wang , Y Xie , L Qian , ... , S Zhang
Frontiers in Pharmacology , 2024 - VOLUME 15
Editorial Retractions, Expressions of Concern and External Notices
Stimulation of hair regrowth in an animal model of androgenic alopecia using 2-deoxy-D-ribose
MA Anjum , S Zulfiqar , AA Chaudhary , ... , S MacNeil
Frontiers in Pharmacology2024 - VOLUME 15 p 1370833.
0 44
![Free / Open Access to Full Text](/assets/img/misc/oa3.png)
AT Prananda , A Dalimunthe , U Harahap , ... , F Nurkolis
Frontiers in Pharmacology2023 - VOLUME 14 p 1288618.
3 97
![Free / Open Access to Full Text](/assets/img/misc/oa3.png)
L Ma , Y Cao , F Wang , ... , H Li
Frontiers in Pharmacology2020 - VOLUME 11 p 510.
3 45
![Free / Open Access to Full Text](/assets/img/misc/oa3.png)
Frontiers in Pharmacology
2024 - VOLUME 15
0 1
![Free / Open Access to Full Text](/assets/img/misc/oa3.png)
PubPeer
2022 - VOLUME 2022, ISSUE 4
0 0
![Free / Open Access to Full Text](/assets/img/misc/oa3.png)
Antiplatelet Agents Have a Distinct Efficacy on Platelet Aggregation Induced by Infectious Bacteria.
N Hannachi , E Ogé-Ganaye , JP Baudoin , ... , L Camoin-Jau
Frontiers in Pharmacology2020 - VOLUME 11 p 863.
10 34
![Free / Open Access to Full Text](/assets/img/misc/oa3.png)
AA Mohamed , R El Borolossy , EM Salah , ... , AA El Kholy
Frontiers in Pharmacology2023 - VOLUME 14 p 1202325.
4 48
![Free / Open Access to Full Text](/assets/img/misc/oa3.png)
N Muhammad , M Ahmad , M Sirajuddin , ... , AG Al-Sehemi
Frontiers in Pharmacology2022 - VOLUME 13 p 864336.
7 46
![Free / Open Access to Full Text](/assets/img/misc/oa3.png)